140 related articles for article (PubMed ID: 25266049)
1. Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study.
Kasenda B; Bass A; Koeberle D; Pestalozzi B; Borner M; Herrmann R; Jost L; Lohri A; Hess V
BMC Cancer; 2014 Sep; 14():728. PubMed ID: 25266049
[TBL] [Abstract][Full Text] [Related]
2. Body mass index does not affect the survival of pancreatic cancer patients.
Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
[TBL] [Abstract][Full Text] [Related]
3. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
Li D; Morris JS; Liu J; Hassan MM; Day RS; Bondy ML; Abbruzzese JL
JAMA; 2009 Jun; 301(24):2553-62. PubMed ID: 19549972
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.
Peixoto RD; Speers C; McGahan CE; Renouf DJ; Schaeffer DF; Kennecke HF
Cancer Med; 2015 Aug; 4(8):1171-7. PubMed ID: 25891650
[TBL] [Abstract][Full Text] [Related]
5. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.
Bagni K; Chen IM; Johansen AZ; Dehlendorff C; Jensen BV; Hansen CP; Preus Hasselby J; Holländer NH; Nissen M; Bjerregaard JK; Pfeiffer P; Yilmaz MK; Rasmussen LS; Nielsen SE; Johansen JS
Eur J Cancer Care (Engl); 2020 May; 29(3):e13219. PubMed ID: 31908093
[TBL] [Abstract][Full Text] [Related]
7. Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients.
Kang J; Lee SH; Son JH; Lee JW; Choi YH; Choi JH; Paik WH; Ryu JK; Kim YT
PLoS One; 2018; 13(4):e0195118. PubMed ID: 29608578
[TBL] [Abstract][Full Text] [Related]
8. A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).
Al-Saleh K; Abd El-Aziz N; Ali A; Abo Zeed W; Salah T; Elsamany S; Rasmy A; El Farargy O; Husain S; Al-Rikabi A; Alsaeed E; Aldiab A; Abd El-Warith A
Gulf J Oncolog; 2019 May; 1(30):33-42. PubMed ID: 31242980
[TBL] [Abstract][Full Text] [Related]
9. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC).
Lam VK; Bentzen SM; Mohindra P; Nichols EM; Bhooshan N; Vyfhuis M; Scilla KA; Feigenberg SJ; Edelman MJ; Feliciano JL
Lung Cancer; 2017 Feb; 104():52-57. PubMed ID: 28213000
[TBL] [Abstract][Full Text] [Related]
10. Adolescent overweight and obesity and the risk for pancreatic cancer among men and women: a nationwide study of 1.79 million Israeli adolescents.
Zohar L; Rottenberg Y; Twig G; Katz L; Leiba A; Derazne E; Tzur D; Eizenstein S; Keinan-Boker L; Afek A; Kark JD
Cancer; 2019 Jan; 125(1):118-126. PubMed ID: 30417331
[TBL] [Abstract][Full Text] [Related]
11. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH
Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261
[TBL] [Abstract][Full Text] [Related]
12. Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue.
Iyengar NM; Kochhar A; Morris PG; Morris LG; Zhou XK; Ghossein RA; Pino A; Fury MG; Pfister DG; Patel SG; Boyle JO; Hudis CA; Dannenberg AJ
Cancer; 2014 Apr; 120(7):983-91. PubMed ID: 24449483
[TBL] [Abstract][Full Text] [Related]
13. Impact of Body Mass Index on Survival of Pancreatic Cancer Patients in Japan.
Okura T; Fujii M; Shiode J; Ito Y; Kojima T; Nasu J; Niguma T; Yoshioka M; Mimura T; Yamamoto K
Acta Med Okayama; 2018 Apr; 72(2):129-135. PubMed ID: 29674761
[TBL] [Abstract][Full Text] [Related]
14. Prediagnostic body mass index and pancreatic cancer survival.
Yuan C; Bao Y; Wu C; Kraft P; Ogino S; Ng K; Qian ZR; Rubinson DA; Stampfer MJ; Giovannucci EL; Wolpin BM
J Clin Oncol; 2013 Nov; 31(33):4229-34. PubMed ID: 24145341
[TBL] [Abstract][Full Text] [Related]
15. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
16. Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials.
Dahlberg SE; Schiller JH; Bonomi PB; Sandler AB; Brahmer JR; Ramalingam SS; Johnson DH
J Thorac Oncol; 2013 Sep; 8(9):1121-7. PubMed ID: 23887169
[TBL] [Abstract][Full Text] [Related]
17. Influence of obesity and other risk factors on survival outcomes in patients undergoing pancreaticoduodenectomy for pancreatic cancer.
Dandona M; Linehan D; Hawkins W; Strasberg S; Gao F; Wang-Gillam A
Pancreas; 2011 Aug; 40(6):931-7. PubMed ID: 21747317
[TBL] [Abstract][Full Text] [Related]
18. Body mass index and mortality in patients with gastric cancer: a large cohort study.
Lee JH; Park B; Joo J; Kook MC; Kim YI; Lee JY; Kim CG; Choi IJ; Eom BW; Yoon HM; Ryu KW; Kim YW; Cho SJ
Gastric Cancer; 2018 Nov; 21(6):913-924. PubMed ID: 29651648
[TBL] [Abstract][Full Text] [Related]
19. FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience.
Moretto R; Raimondo L; De Stefano A; Cella CA; Matano E; De Placido S; Carlomagno C
Anticancer Drugs; 2013 Oct; 24(9):980-5. PubMed ID: 23928570
[TBL] [Abstract][Full Text] [Related]
20. First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors.
Vivaldi C; Caparello C; Musettini G; Pasquini G; Catanese S; Fornaro L; Lencioni M; Falcone A; Vasile E
Int J Cancer; 2016 Aug; 139(4):938-45. PubMed ID: 27038273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
